Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Trump, first lady set for Washington Trump–Kennedy Center...
Trump-Kennedy Center blasts ‘far-left bias’ in ratings coverage,...
Senate Republicans eye reconciliation to address Minnesota fraud...
BROOKE ROLLINS, ROBERT KENNEDY JR: New dietary plan...
5 GOP senators join Democrats to stop Trump...
Senate Dem John Fetterman supports prospect of US...
Vance calls Walz ‘a joke,’ claims Minnesota governor...
JD Vance announces multi-state fraud task force in...
Trump calls for $1.5T defense budget to build...
Trump blasts GOP war powers defectors, says they...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

Providence Gold Mines Inc. Options La Dama de...

August 21, 2025

E-Tech Resources Identifies Kilometer-Scale REE Soil Anomaly at...

October 1, 2025

1911 Gold Intersects up to 24.83 g/t Gold...

November 11, 2025

Galloper Gold Corporate Update

August 31, 2024

Heritage Mining Confirms New Gold Mineralization at the...

September 16, 2025

Forte Minerals Secures C$5.7 Million Strategic Investment to...

July 16, 2025

Director led financing and change of Chairman

May 14, 2025

Prismo Metals Announces Closing of Private Placement

January 1, 2026

Top 5 Small-cap Pharma Stocks (Updated January 2025)

January 14, 2025

Allied Critical Metals Drills 10.0 Metres of 1.11%...

October 22, 2025

Recent Posts

  • Trump, first lady set for Washington Trump–Kennedy Center premiere of ‘MELANIA’ ahead of global release
  • Trump-Kennedy Center blasts ‘far-left bias’ in ratings coverage, points to No. 1 demographics tie
  • Senate Republicans eye reconciliation to address Minnesota fraud scandal
  • BROOKE ROLLINS, ROBERT KENNEDY JR: New dietary plan recommends real food for all Americans
  • 5 GOP senators join Democrats to stop Trump from policing Venezuela

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (964)
    • Investing (3,824)
    • Politics (4,621)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.